XML 79 R67.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Based Compensation (Details) - Schedule of company’s stock option activity
9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Options Shares    
Beginning Balance (in shares) | shares 11,571,308  
Granted/Vested during the year (in shares) | shares 1,115,874  
Exercised during the year (in shares) | shares (493,984)  
Cancelled during the year (in shares) | shares (551,665)  
Ending Balance (in shares) | shares 11,641,533 11,571,308
Options Shares, Options vested and exercisable (in shares) | shares 2,937,143  
Weighted Average Exercise Price    
Beginning balance (in dollars per share) | $ / shares $ 7.11  
Granted/Vested during the year (in dollars per share) | $ / shares 8.92  
Exercised during the year (in dollars per share) | $ / shares 3.63  
Cancelled during the year (in dollars per share) | $ / shares 7.66  
Ending balance (in dollars per share) | $ / shares 7.42 $ 7.11
Weighted Average Exercise Price, Options vested and exercisable (in dollars per share) | $ / shares $ 6.36  
Weighted Average Remaining Contractual Life in Years    
Weighted average remaining contractual life in years 8 years 5 months 19 days 9 years 18 days
Weighted Average Remaining Contractual Life in Years, Options vested and exercisable 7 years 7 months 24 days  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]    
Aggregate Intrinsic Value | $ $ 49,268,644 $ 39,389,063
Aggregate Intrinsic Value, Options vested and exercisable | $ $ 3,060,026